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Abstract 
Deletions in 15q13.3 belong to the most frequently identified recurrent CNVs, and 
lead to mental retardation, seizures and minor dysmorphism. We report on two 
monozygotic twin boys with a mosaic 1.5 Mb deletion in 15q13.3, including CHRNA7. 
The growth parameters were in the normal range for both twins. Both had language 
delay with hyperactivity, temper tantrums and poor social interaction but attended 
regular school. The percentage of abnormal cells was 40% on lymphocytes, and 25 
and 35% on buccal smear in the first and second twins, respectively. The mosaicism 
for the 15q13.3 deletion can explain the milder phenotype observed in these two 
boys. 
 
Introduction  
The use of array-CGH in large populations of individuals with intellectual disability 
and/or autism has demonstrated that clinically relevant CNVs accounted for a 
significant proportion of cases [1]. In the great majority of cases, these CNVs 
originate prezygotically and are identified in homogenous state in the affected 
individuals. However, in rare cases, the microrearrangements occur postzygotically, 
during the first mitotic divisions of the fertilized oocyte. These divisions are 
chromosomally unstable and can generate blastomeres with various numerical as 
well as structural chromosome abnormalities [2]. Depending on the distribution of 
blastomeres in the developing fetus, the chromosomal anomaly may be identified in 
homogenous or mosaic state. To date, evidence for mosaic microdeletions has been 
obtained pre or postnatally only for a very limited number of microrearrangement, 
including microdeletions in 16p11.2, 17p11.2p12, 22q11.2 or 22q13 [3-7].  
Among recurrent CNVs, 15q13.3 deletion is one of the most frequently identified 
microrearrangements. Classically, the 1.5 Mb deleted region is located between the 
previously characterized breakpoints BP4–BP5 and contains 6 genes, including 
CHRNA7 (alpha-7 neuronal nicotinic acetylcholine receptor), but larger (between 
BP3–BP5) or smaller (including only the CHRNA7 gene) deletions were reported [8]. 
The phenotype associates mental retardation, seizures and minor dysmorphism. In 
most cases, the deletion is inherited from a carrier parent with a mild or no 
phenotype. To the best of our knowledge, this rearrangement has never been 
reported in a mosaic state. In this paper we report the first couple of twin boys 
presenting with a mosaic 15q13.3-q13.3 microdeletion involving the CHRNA7 gene.  
 
 Clinical description 
These MZ twin boys, born from the first pregnancy of a healthy 23 year-old mother 
and a 32 year-old unrelated father, were referred to our clinical genetics service for 
developmental delay. Family history was unremarkable. Delivery took place at 37 
week gestation. Birth weights were 2.3 and 2.6 kg, lengths 46.5 and 48 cm and head 
circumference 32.5 and 33 cm. Both twins had a hypospadias. Motor milestones 
were in the normal range with walking achieved at 18 months. Language was 
delayed. Parents reported behavioral disturbances with hyperactivity, temper 
tantrums and poor social interaction. Boys attended regular school. On examination 
at age 6 years, growth parameters were in the normal range for both twins: height: 
113 cm (M); weight: 19 and 20 kg; head circumference: 51.5 and 52 cm (between M 
and -1SD). They exhibited striking facial resemblance with high and prominent 
forehead, deep set eyes, thin upper lip and large ears.  
 
 
Materials and Methods 
Conventional and molecular cytogenetic analyses were done on peripheral blood 
lymphocytes using standard techniques. The array-CGH analysis was performed on 
the high resolution whole-genome oligo-array SurePrint G3 Human CGH 4x180K 
Oligo Microarray Kit G4449A (Agilent Technologies, Massy, France) according to 
Agilent’s protocol using DNA extracted from peripheral whole blood using a saline 
precipitation method. The data were processed using Agilent Feature Extraction and 
DNA Analytics softwares (both from Agilent Technologies), with the statistical 
algorithm ADM-2, sensitivity threshold 5 and at least 3 consecutive aberrant probes. 
 The zygozity was assessed by genotyping of eleven microsatellite markers located 
on chromosomes 14 and 15, and by analysis of the 26 polymorphic CNVs identified 
by array-CGH in the two twins.  
 
Genomic rearrangement 
Conventional cytogenetic analysis by RHG banding showed a normal karyotype at 
the 550 bands resolution for both twins. The array-CGH analysis revealed a 1.5 Mb 
microdeletion at 15q13.2 – q13.3 (Fig. 1A and B), ranging from genomic position 
28,758,822 to 30,226,176 (first and last deleted probes, hg 18) and covering the 
CHRNA7 gene. The average value of the log2 ratio suggested the presence of a 
mosaic deletion, the proportion of cells with deletion being estimated between 30 and 
40%. The mosaicism was confirmed by metaphase FISH on cultured lymphocytes 
with BAC clone CTD-3242G24 (chr15:24,949,159-25,084,127, hg 18) covering the 
CHRNA7 gene, 40% of examined metaphases showing the deletion. To exclude a 
twin-to-twin blood transfusion, interphase FISH was performed on buccal epithelial 
cells, showing 35% and 25% cells with the deletion in the first and second twin, 
respectively. All identified structural polymorphisms and all analyzed microsatellite 
polymorphisms were shared by both twins, thus confirming the monozygozity. 
 
Discussion 
In this paper we report a couple of monozygotic twin boys with classical 15q13.2-
q13.3 deletion between BP4–BP5 involving the CHRNA7 gene in a mosaic state. 
CHRNA7 encodes the subunit alpha 7 of the neuronal cholinergic receptors, which 
are involved in synaptic transmission throughout the peripheral and central nervous 
system [9].  
Our report provides new data concerning the mechanism and the timing of 
occurrence of the 15q13.3-q13.3 microdeletion. Regarding the mechanism, initially it 
was postulated that chromosomal rearrangements at the origin of recurrent 
microdeletion/microduplication syndromes occur in meiosis, mainly by a meiotic 
nonallelic homologous recombination (NAHR) mechanism. Later, the identification of 
mosaic cases in some microrearrangements pointed to another alternate mechanism, 
the postzygotic, mitotic NAHR. The frequency of mitotic NAHR is variable among 
different rearrangements, from very rare or anecdotal in some recurrent 
rearrangements such as microdeletions 16p11.2, 17p11.2p12, 22q11.2 or 22q13 [3-
7], to very frequent in the type 2 NF1 microdeletions, which are predominantly of 
postzygotic origin [10]. A survey of the literature using the key words “mosaic”, 
“deletion” and “15q13” or “CHRNA7” failed to return any item. Thus, to the best of our 
knowledge, the present report is the first description of patients with mosaic 15q13.3 
deletion resulting by postzygotic NAHR.  
Regarding the timing of occurrence of the 15q13.3-q13.3 microdeletion by the 
postzygotic NAHR, the identification of the same mosaic state in the monozygotic 
twins allows placing the NAHR occurrence on the embryonic developmental time 
scale. For years, it has been postulated that MZ twins are genetically identical and 
that phenotypic differences between twins are mainly due to environmental factors. 
There is an increasing body of evidence pointing to genetic differences between MZ 
twins, due to somatic mosaicism. These differences may explain at least in part the 
phenotypic differences. CNV differences are more frequent in phenotypically 
discordant twins but occur in concordant twins pairs [11]. At the opposite, in the 
present report both twins are clinically concordant and exhibit the same mosaic 
pattern, suggesting that the somatic recombination of polymorphic regions might 
have occurred at a relatively early stage in embryonic development. The twinning 
process occurs early in the development, the pattern of placentation being a 
reference mark for the time of cell mass splitting: if separation occurs before the first 
three days post fertilization the twins are dichorionic diamniotic, between three to 
nine days post fertilization monochorionic diamniotic, and, if splitting occurs after nine 
days post fertilization, monochorionic monoamniotic. The subsequent distribution of 
cellular clones among different tissues and organs in the twins may be similar or 
different, the twins being phenotypically concordant or discordant. In both twins the 
deletion was present in blood lymphocytes in a similar proportion, around of 40% of 
examined metaphases, but slight differences were observed in buccal smear. 
Unfortunately, we know neither the placentation pattern, nor the distribution of the 
abnormal cellular clone among the fetal annexes. Thus, to the best we only can 
suppose the occurrence of somatic NAHR before the eleventh-twelfth days post 
fertilization.  
The heterozygous 15q13.3 microdeletion is characterized by phenotypic variability 
ranging from a full phenotype, with seizures, developmental delay, and subtle facial 
dysmorphism, to an incomplete penetrance [12]. Homozygous deletion gives rise to a 
much more severe clinical picture, even in the case of the small deletion containing 
only the CHRNA7 gene, confirming the major role of this gene’s haploinsufficiency in 
the phenotype. The case under report illustrates the milder end of the phenotypic 
spectrum, the two boys presenting the CNV in 40% of lymphocytes and showing a 
milder phenotype compared with the one usually observed in children carrying this 
microdeletion. However, the proportion of deleted cells may be different in neurons 
and any correlation between somatic mosaicism identified in lymphocytes and the 
severity of phenotype must be made with caution. In a case of 50% mosaic 7q31 
deletion involving FOXP2, the phenotype did not appear to be milder than in other 
reported cases [13]. Conversely, somatic mosaicism has also been reported in 
asymptomatic parents of children carrying deletions, such as in Kleefstra syndrome 
[14]. An increasing body of literature demonstrates the role of somatic mosaicism in 
sporadic diseases. Recently, in patients with segmental overgrowth disorders like 
Proteus syndrome, hemimegalencephaly and fibroadipose hyperplasia, somatic gain-
of-function mutations were identified in genes acting in the PI3K-AKT-mTOR pathway 
[15]. Although it is still too early to attempt to draw conclusions, at least in some 
situations it would seem that a relationship exists between the tissue mutation burden 
and the phenotype. In the same way, tissue specific presence of de novo somatic 
CNVs or large variations in the proportion of cell lines with or without a CNV among 
different tissues can explain the phenotypic discrepancies observed in some patients. 
Provided that the tissue material is available, array-CGH analysis is a powerful 
technique for identifying tissue-specific mosaicism for genomic imbalances from 10% 
abnormal cells [16]. 
In conclusion, this is the first report of mosaic 15q13.2-q13.3 deletion in monozygotic 
twins. The percentage of abnormal cells, between 25 and 40% in different tissues, 
can explain the milder phenotype observed in these two boys. However, due to the 
phenotypic variability observed among 15q13 carriers, we cannot exclude that the 
milder phenotype observed in twins denotes the mild end of the clinical spectrum. 
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Figure Titles and Legends 
 
Figure 1. Array-CGH analysis in monozygotic twin boys (T1 and T2) showing (A) 
whole chromosome 15 log2 plot with the mosaic 15q13.2-q13.3 deletion (arrowhead) 
and (B) zoom in of the 15q13.2-q13.3 deleted region (the limits of the deleted region 
are marked by double arrowheads). The imbalance was confirmed by metaphase 
FISH analysis on lymphocytes with BAC probe CTD-3242G24 corresponding to the 
CHRNA7 gene (arrowhead) and TelVysion 15q probe (double arrowhead) (C) and by 
interphase FISH analysis on buccal smear with BAC probe CTD-3242G24 (D). 
 
 
